WallStreetZenWallStreetZen

NASDAQ: TSHA
Taysha Gene Therapies Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Taysha Gene Therapies revenue was $7.22M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $2.3M, up 13.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TSHA annual revenue was $8.3M, with -46.1% growth year-over-year.

TSHA past revenue growth

How has TSHA's revenue growth performed historically?

Company
-48.97%
Industry
1,361.15%
Market
34.96%
TSHA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TSHA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

TSHA revenue history

Current Revenue
$7.2M
Current Earnings
-$86.8M
Current Profit Margin
-1,201.1%

Be the first to know when TSHA announces revenue.

TSHA Revenue History By Year

TSHA Yearly RevenueTSHA RevenueTSHA ChangeTSHA Revenue Growth
2024-12-31$8.33M-$7.12M-46.07%
2023-12-31$15.45M$12.95M+517.55%
2022-12-31$2.50MN/AN/A
2021-12-31$0.00N/AN/A
2020-12-31$0.00N/AN/A

1 of 1

Taysha Gene Therapies Revenue FAQ

What was TSHA's revenue last quarter?

On Invalid Date, Taysha Gene Therapies (NASDAQ: TSHA) reported Q1 2025 revenue of $2.30 million up 32.51% year over year. In the same quarter last year, Taysha Gene Therapies's revenue was $3.41 million.

What was Taysha Gene Therapies's revenue in 2024?

Taysha Gene Therapies's annual revenue for the twelve months ending Dec 31, 2024 was $8.33 million, a 46.07% decrease year over year.

How much does Taysha Gene Therapies make in a day?

Based on Taysha Gene Therapies annual revenue for the past four years, TSHA makes an average of $18,004.11 per day.

What was Taysha Gene Therapies's annual revenue growth in the past year?

As of Q2 2025, Taysha Gene Therapies's revenue has grown -48.97% year over year. This is 1,410.11 percentage points lower than the US Biotechnology industry revenue growth rate of 1,361.15%. Taysha Gene Therapies's revenue in the past year totaled $7.22 million.

How much does Taysha Gene Therapies make in a year?

Taysha Gene Therapies's revenue by year for the past four years is:
  • Taysha Gene Therapies's revenue for the twelve months ending Dec 31, 2024 was $8.33 million, a 46.07% decrease year over year.
  • Taysha Gene Therapies's annual revenue for Dec 31, 2023 was $15.45 million, a 517.55% increase from 2022.
  • Taysha Gene Therapies's annual revenue for 2022 was $2.50 million, a Infinity% increase from 2021.
  • Taysha Gene Therapies's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.